856. Industry
Session: Symposium: Susceptibility Breakpoints Controversies and Consensus
Saturday, October 23, 2010: 11:30 AM
Parkview Terrace / 1-3

Glenn Tillotson, PhD, FIDSA , ViroPharma Incorporated, Exton, PA


G. Tillotson, Yes
ViroPharma Incorporated: Employee, Salary

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 21 with the exception of research findings presented at IDSA press conferences.


Copyright IDSA 2009 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org